Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 53% ± 19% | |
peripheral blood | 21 studies | 61% ± 20% | |
brain | 21 studies | 46% ± 19% | |
intestine | 11 studies | 50% ± 24% | |
eye | 10 studies | 45% ± 18% | |
kidney | 9 studies | 50% ± 15% | |
liver | 7 studies | 43% ± 19% | |
bone marrow | 6 studies | 42% ± 25% | |
lymph node | 6 studies | 60% ± 17% | |
heart | 6 studies | 31% ± 8% | |
uterus | 5 studies | 61% ± 20% | |
prostate | 5 studies | 46% ± 19% | |
breast | 5 studies | 54% ± 20% | |
placenta | 4 studies | 53% ± 20% | |
esophagus | 4 studies | 48% ± 28% | |
skin | 4 studies | 45% ± 16% | |
adipose | 4 studies | 48% ± 19% | |
pancreas | 3 studies | 56% ± 23% | |
adrenal gland | 3 studies | 49% ± 17% | |
stomach | 3 studies | 49% ± 31% | |
thymus | 3 studies | 67% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 25935.70 | 459 / 459 | 100% | 136.32 | 1118 / 1118 |
esophagus | 100% | 22053.24 | 1445 / 1445 | 100% | 113.19 | 183 / 183 |
lung | 100% | 27318.38 | 578 / 578 | 100% | 115.85 | 1155 / 1155 |
ovary | 100% | 34976.18 | 180 / 180 | 100% | 87.39 | 430 / 430 |
pancreas | 100% | 14374.56 | 328 / 328 | 100% | 136.88 | 178 / 178 |
uterus | 100% | 31912.54 | 170 / 170 | 100% | 143.58 | 459 / 459 |
intestine | 100% | 24940.74 | 966 / 966 | 100% | 102.29 | 526 / 527 |
prostate | 100% | 23946.85 | 245 / 245 | 100% | 127.96 | 501 / 502 |
kidney | 100% | 19198.99 | 89 / 89 | 100% | 111.12 | 899 / 901 |
brain | 100% | 18982.70 | 2636 / 2642 | 100% | 209.50 | 705 / 705 |
thymus | 100% | 26540.74 | 653 / 653 | 100% | 151.98 | 603 / 605 |
stomach | 100% | 18203.06 | 359 / 359 | 100% | 93.93 | 285 / 286 |
bladder | 100% | 22773.52 | 21 / 21 | 99% | 117.98 | 501 / 504 |
skin | 100% | 20972.63 | 1809 / 1809 | 99% | 120.17 | 469 / 472 |
adrenal gland | 100% | 17157.77 | 258 / 258 | 99% | 125.37 | 228 / 230 |
liver | 100% | 9730.25 | 226 / 226 | 98% | 60.72 | 396 / 406 |
adipose | 100% | 23250.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 128.85 | 29 / 29 |
spleen | 100% | 25801.89 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 113.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 101.53 | 1 / 1 |
blood vessel | 100% | 24851.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 18326.46 | 802 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 106.79 | 79 / 80 |
heart | 98% | 12877.03 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 9151.02 | 705 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0003677 | Molecular function | DNA binding |
GO_0008143 | Molecular function | poly(A) binding |
GO_0005515 | Molecular function | protein binding |
GO_0034046 | Molecular function | poly(G) binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HNRNPDL |
Protein name | Heterogeneous nuclear ribonucleoprotein D like Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1) Heterogeneous nuclear ribonucleoprotein D like (Heterogeneous nuclear ribonucleoprotein D-like, isoform CRA_b) |
Synonyms | hCG_22986 HNRPDL JKTBP |
Description | FUNCTION: Acts as a transcriptional regulator. Promotes transcription repression. Promotes transcription activation in differentiated myotubes (By similarity). Binds to double- and single-stranded DNA sequences. Binds to the transcription suppressor CATR sequence of the COX5B promoter (By similarity). Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Binds both to nuclear and cytoplasmic poly(A) mRNAs. Binds to poly(G) and poly(A), but not to poly(U) or poly(C) RNA homopolymers. Binds to the 5'-ACUAGC-3' RNA consensus sequence. . |
Accessions | A0A087WUK2 ENST00000614627.4 A0A087WU03 ENST00000507721.5 [O14979-2] ENST00000514511.1 ENST00000621267.4 [O14979-1] ENST00000630827.1 [O14979-2] ENST00000349655.8 [O14979-2] O14979 ENST00000295470.10 [O14979-1] ENST00000602300.5 [O14979-2] ENST00000502762.4 [O14979-1] ENST00000630114.2 [O14979-2] |